Sodium Picosulfate

BreastfeedingPediatric
  • TRADE NAMES: Pico-Salax (Ferring); Prepopik (Ferring)
  • INDICATIONS: Laxative for colon cleansing prior to colonoscopy
  • CLASS: Stimulant laxative
  • HALF-LIFE: ~7 hours

FDA APPROVAL DATE: 07/17/2012

CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Antibiotics, Antipsychotics, Carbamazepine, Cardiac glycosides, Chlorpromazine, Corticosteroids, Digoxin, Diuretics, NSAIDs, Oral iron, Penicillamine, SSRIs, Tetracycline, Tricyclic antidepressants

PREGNANCY CATEGORY: B

Prepopik is a combination of sodium picosulfate and magnesium citrate.

Contra-indicated in patients with severely reduced renal function, gastrointestinal obstruction or ileus, bowel perforation, toxic colitis or toxic megacolon, or gastric retention.

Our database has 15 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
NEUROMUSCULAR/SKELETAL.
OTHER.


Page last updated 09/03/2019

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top